Performance of the fractional maximal effect method: Comparative interaction studies of ciprofloxacin and protein synthesis inhibitors

Journal of Chemotherapy

Volumn 8, Issue 1, 1996, Pages 25-32

  Li, R C ^a   Nix, D E ^b   Schentag, J J ^b,c  

^a and Hong Kong Branch of CAS Center for Excellence in Animal Evolution and Genetics   (Hong Kong)

^b MILLARD FILLMORE HOSPITAL   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

Ciprofloxacin; Comparison; Conventional assay methods; Fractional maximal effect method; Interaction; Protein synthesis inhibitors

Indexed keywords

AMOXICILLIN; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; PROTEIN SYNTHESIS INHIBITOR; TETRACYCLINE; TICARCILLIN; TOBRAMYCIN;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; DRUG ANTAGONISM; DRUG POTENTIATION; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PSEUDOMONAS AERUGINOSA;

EID: 0030021279     PISSN: 1120009X     EISSN: None     Source Type: Journal    
DOI: 10.1179/joc.1996.8.1.25     Document Type: Article

References (22)

1. Berenbaum MC. A method for testing for synergy with any number of agents. J Infect Dis 1978; 137: 122-130.
2. Hall MJ, Middleton RF, Westmacott D. The fractional inhibitory concentration (FIC) index as a measure of synergy. J Antimicrob Chemother 1983; 11: 427-433.
3. Hallander HO, Dornbusch K, Gezelius L, Jocobson K, Karlsoon I. Synergism between aminoglycosides and cephalosporins with antipseudomonal activity: interaction index and killing curve method. Antimicrob Agents Chemother 1982; 22: 743-752.
4. Klastersky J, Meunier-Carpentier F, Prevost JM, Staquet M. Synergism between amikacin and cefazolin against Klebsiella: in vitro studies and effect on the bactericidal activity of serum. J Infect Dis 1976; 134: 271-276.
5. Moody JA, Gerding DN, Peterson LR. Evaluation of ciprofloxacin's synergism with other agents by multiple in vitro methods. Am J Med 1987; 82(Suppl.4A): 44-54.
6. Norden CW, Wentzel H, Keleti E. Comparison of techniques for measurement of in vitro antibiotic synergism. J Infect Dis 1979; 140: 629-633.
7. Elion GB, Singer S, Hitchings CH. Antagonists of nucleic acid derivatives. VIII Synergism in combinations of biochemically related antimetabolites. J Biol Chem 1954; 208: 477-488.
8. Mattie H. Kinetics of antimicrobial action. Rev Infect Dis 1981; 3: 19-27.
9. Tsuji A, Hamano S, Asano T, Nakashima E, Yamana T, Mitsuhashi S. Microbial kinetics of β-lactam antibiotics against Escherichia coli. J Pharm Sci 1984; 73: 1418-1422.
10. Weinstein RJ, Young LS, Hewitt WL. Comparison of methods for assessing in vitro antibiotic synergism against Pseudomonas and Serratia. J Lab Clin Med 1975; 86: 853-862.
11. Thomas FE Jr, Leonard JM, Alford RH. Sulfamethoxazole-trimethoprim-polymyxin therapy of serious multiply drug-resistant Serratia infections. Antimicrob Agents Chemother 1976; 9: 201-207.
12. Garrett ER, Heman-Ackah SM. Microbial kinetics and dependencies of individual and combined antibiotic inhibitors of protein biosynthesis. Antimicrob Agents Chemother 1973; 4:574-584.
13. Li RC, Nix DE, Schentag JJ. Pharmacodynamic modeling of bacterial kinetics: β-lactam antibiotics against Escherichia coli. J Pharm Sci 1994; 83: 970-975.
14. Li RC, Schentag JJ, Nix DE. The fractional maximal effect method: a new way to characterize the effect of antibiotic combinations and other nonlinear pharmacodynamic interactions. Antimicrob Agents Chemother 1993; 37: 523-531.
15. 14C-labeled streptomycin by Enterococci. J Clin Invest 1971; 50: 2580-2584.
16. Rahal JJ Jr. Antibiotic combinations: the clinical relevance of synergy and antagonism. Medicine 1978; 57: 179-195.
17. Neu HC. Synergy of Fluoroquinolones with other antimicrobial agents. Rev Infect Dis 1989; 11(Suppl.5): S1025-S1035.
18. Zeiler HJ. Bactericidal action of ciprofloxacin. Proceedings of 1st International Ciprofloxacin Workshop, Leverkusen. 1985: 20-25
19. CrumpIin GC, Smith JT. Nalidixic acid: an antibacterial paradox. Antimicrob Agents Chemother 1975; 8: 251-261.
20. Smith JT. Awakening the slumbering potential of the 4-quinolone antibacterials. Pharmaceut J 1984; 233: 299-305.
21. Davies JE. Aminoglycoside-aminocyclitol antibiotics and their modifying enzymes. In: Lorian V, ed. Antibiotics in Laboratory Medicine, 3rd ed., Baltimore: The Williams and Wilkins Co., 1991: 691-713
22. Hilf M, Yu VL, Sharp J, Zuravleff J, Korvick JA, Muder RR. Antibiotic therapy for Pseudomonas aeruginosa bacteremia: outcome correlations in a prospective study of 200 patients. Am J Med 1989; 87: 540-546.